Your browser doesn't support javascript.
loading
FGF7-FGFR2 autocrine signaling increases growth and chemoresistance of fusion-positive rhabdomyosarcomas.
Milton, Christopher I; Selfe, Joanna; Aladowicz, Ewa; Man, Stella Y K; Bernauer, Carolina; Missiaglia, Edoardo; Walters, Zoë S; Gatz, Susanne A; Kelsey, Anna; Generali, Melanie; Box, Gary; Valenti, Melanie; de Haven-Brandon, Alexis; Galiwango, David; Hayes, Angela; Clarke, Matthew; Izquierdo, Elisa; Gonzalez De Castro, David; Raynaud, Florence I; Kirkin, Vladimir; Shipley, Janet M.
Afiliação
  • Milton CI; Sarcoma Molecular Pathology Team, Divisions of Molecular Pathology and Cancer Therapeutics, The Institute of Cancer Research, London, UK.
  • Selfe J; Sarcoma Molecular Pathology Team, Divisions of Molecular Pathology and Cancer Therapeutics, The Institute of Cancer Research, London, UK.
  • Aladowicz E; Sarcoma Molecular Pathology Team, Divisions of Molecular Pathology and Cancer Therapeutics, The Institute of Cancer Research, London, UK.
  • Man SYK; Sarcoma Molecular Pathology Team, Divisions of Molecular Pathology and Cancer Therapeutics, The Institute of Cancer Research, London, UK.
  • Bernauer C; Sarcoma Molecular Pathology Team, Divisions of Molecular Pathology and Cancer Therapeutics, The Institute of Cancer Research, London, UK.
  • Missiaglia E; Sarcoma Molecular Pathology Team, Divisions of Molecular Pathology and Cancer Therapeutics, The Institute of Cancer Research, London, UK.
  • Walters ZS; Sarcoma Molecular Pathology Team, Divisions of Molecular Pathology and Cancer Therapeutics, The Institute of Cancer Research, London, UK.
  • Gatz SA; Sarcoma Molecular Pathology Team, Divisions of Molecular Pathology and Cancer Therapeutics, The Institute of Cancer Research, London, UK.
  • Kelsey A; Department of Paediatric Histopathology, Manchester University NHS Foundation Trust, Royal Manchester Children's Hospital, UK.
  • Generali M; Sarcoma Molecular Pathology Team, Divisions of Molecular Pathology and Cancer Therapeutics, The Institute of Cancer Research, London, UK.
  • Box G; Cancer Pharmacology and Stress Response Team, Division of Cancer Therapeutics, The Institute of Cancer Research, London, UK.
  • Valenti M; Cancer Pharmacology and Stress Response Team, Division of Cancer Therapeutics, The Institute of Cancer Research, London, UK.
  • de Haven-Brandon A; Cancer Pharmacology and Stress Response Team, Division of Cancer Therapeutics, The Institute of Cancer Research, London, UK.
  • Galiwango D; Drug Metabolism and Pharmacokinetics Team, Division of Cancer Therapeutics, The Institute of Cancer Research, London, UK.
  • Hayes A; Drug Metabolism and Pharmacokinetics Team, Division of Cancer Therapeutics, The Institute of Cancer Research, London, UK.
  • Clarke M; Glioma Team, Division of Molecular Pathology, The Institute of Cancer Research, London, UK.
  • Izquierdo E; Glioma Team, Division of Molecular Pathology, The Institute of Cancer Research, London, UK.
  • Gonzalez De Castro D; Molecular Haematology, Division of Molecular Pathology, The Institute of Cancer Research, London, UK.
  • Raynaud FI; Drug Metabolism and Pharmacokinetics Team, Division of Cancer Therapeutics, The Institute of Cancer Research, London, UK.
  • Kirkin V; Cancer Pharmacology and Stress Response Team, Division of Cancer Therapeutics, The Institute of Cancer Research, London, UK.
  • Shipley JM; Sarcoma Molecular Pathology Team, Divisions of Molecular Pathology and Cancer Therapeutics, The Institute of Cancer Research, London, UK.
Mol Oncol ; 16(6): 1272-1289, 2022 03.
Article em En | MEDLINE | ID: mdl-34850536
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Rabdomiossarcoma / Comunicação Autócrina Limite: Child / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Rabdomiossarcoma / Comunicação Autócrina Limite: Child / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article